Company Description:

STAT (https://www.statnews.com/) is a leading, national, online media publication reporting from the frontiers of health and medicine. At almost four years old, STAT is a late-stage startup with a fast-paced environment, eager to continue growing it’s national reputation.

Our premium content offering, STAT Plus (https://www.statnews.com/stat-plus/), provides access to exclusive, in-depth coverage on early science and clinical trials, pharma, and biotech news on Wall Street, policy developments in Washington, and disruption in health care in Silicon Valley and beyond. The subscription also includes exclusive access to events, panel discussions, and much more.